Gene · 8835
Papers2,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiRNA Differences Related to Treatment-Resistant Schizophrenia. | Int J Mol Sci | 2023 | 36768211 | PubTator, text mining | PubMed |
F-Box Protein 43, Stabilized by N6-Methyladenosine Methylation, Enhances Hepatocellular Carcinoma Cell Growth and Invasion via Promoting p53 Degradation in a Ubiquitin Conjugating Enzyme E2 C-Dependent Manner. | Cancers (Basel) | 2023 | 36765911 | PubTator, text mining | PubMed |
| Cancer-Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment and Challenges for Cancer Therapy. | Cancers (Basel) | 2023 | 36765683 | PubTator, text mining | PubMed |
| Conserved miR-370-3p/BMP-7 axis regulates the phenotypic change of human vascular smooth muscle cells. | Sci Rep | 2023 | 36765143 | PubTator, text mining | PubMed |
| O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner. | Signal Transduct Target Ther | 2023 | 36765030 | PubTator, text mining | PubMed |
| Identification of androgen response-related lncRNAs in prostate cancer. | Prostate | 2023 | 36760203 | PubTator, text mining | PubMed |
| Interventions with Digital Tools for Mental Health Promotion among 11-18 Year Olds: A Systematic Review and Meta-Analysis. | J Youth Adolesc | 2023 | 36754917 | PubTator, text mining | PubMed |
| PDHB-AS suppresses cervical cancer progression and cisplatin resistance via inhibition on Wnt/β-catenin pathway. | Cell Death Dis | 2023 | 36750722 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognosis of patients with GBM based on 4 m6A-related lncRNAs and immune cell infiltration. | Heliyon | 2023 | 36747529 | PubTator, text mining | PubMed |
| Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape. | J Adv Res | 2023 | 36736694 | PubTator, text mining | PubMed |
| Upregulation of SOCS2 causes mitochondrial dysfunction and promotes ferroptosis in pancreatic cancer cells. | Acta Biochim Pol | 2023 | 36735705 | PubTator, text mining | PubMed |
| Computational approaches for the design of modulators targeting protein-protein interactions. | Expert Opin Drug Discov | 2023 | 36715303 | PubTator, text mining | PubMed |
| Detection of key mRNAs in liver tissue of hepatocellular carcinoma patients based on machine learning and bioinformatics analysis. | MethodsX | 2023 | 36713306 | PubTator, text mining | PubMed |
| METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey. | J Med Chem | 2023 | 36692498 | PubTator, text mining | PubMed |
| Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. | Sci Adv | 2023 | 36662868 | PubTator, text mining | PubMed |
| Length biases in single-cell RNA sequencing of pre-mRNA. | Biophys Rep (N Y) | 2023 | 36660179 | PubTator, text mining | PubMed |
| The Prognostic Value of a lncRNA Risk Model Consists of 9 m6A Regulator-Related lncRNAs in Hepatocellular Carcinoma (HCC). | Evol Bioinform Online | 2023 | 36655172 | PubTator, text mining | PubMed |
| Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology. | Diagnostics (Basel) | 2023 | 36611455 | PubTator, text mining | PubMed |
| ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner. | Exp Hematol Oncol | 2023 | 36609413 | PubTator, text mining | PubMed |
| Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves' disease. | Clin Exp Immunol | 2023 | 36545825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8835/papers?page=17